Trial intelligence / Profile preview

Azithromycin plus Chloroquine vs Atovaquone-Proguanil for Malaria

NCT00084227Phase 3Completed

Sponsor
Pfizer
Start
Jul 2004
Modality
Small Molecules
01

Overview

A Phase 3 trial of azithromycin, chloroquine in Plasmodium falciparum malaria, sponsored by Pfizer. Started Jul 2004; status: completed.

02

Drugs

azithromycinchloroquine
03

Conditions

Plasmodium falciparum malaria

Beyond the preview

Go deeper on NCT00084227.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00084227.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call